Andras Komaromy

Dr. András Komáromy is an Associate Professor in the Department of Small Animal Clinical Sciences at Michigan State University's College of Veterinary Medicine. He also holds adjunct associate professor positions at the University of Pennsylvania and University of Florida. Specializing in comparative ophthalmology, his research focuses on inherited retinal diseases and glaucoma, with particular emphasis on gene therapy development for vision restoration.

Dr. Komáromy earned his Doctor of Veterinary Medicine from the University of Zurich (1996) and PhD in Comparative Ophthalmology from the University of Florida (2002). He completed postdoctoral training at the University of Pennsylvania and is board-certified by both the American and European Colleges of Veterinary Ophthalmologists.

His research program combines inherited retinal disease studies, gene therapy development, and translational glaucoma research, working with canine models that mirror human ocular pathologies. Current projects include ADAMTS10 mutation analysis, retinoid receptor agonist testing, and AAV vector engineering for improved ocular gene delivery.

Scientific Recognition:

• ARVO Gold Fellow (2025)
• Shaffer Prize (2015)
• Fulbright Scholar for Glaucoma Research

Recent grant funding includes:

• NIH-supported glaucoma gene therapy development
• Macquarie University NHMRC collaboration on 'Modified Serpin Therapeutics'
• Foundation Fighting Blindness grants for Stargardt disease modeling
• AbbVie pharmaceutical research partnerships

The Komáromy Laboratory team includes research assistants and collaborators from Temple University, University of Florida, and Cornell University. Their work has established ground-breaking gene therapy treatments for achromatopsia that are now being adapted for human clinical trials.